Disease-stabilizing treatment with all-trans retinoic acid and valproic acid in acute myeloid leukemia: Serum hsp70 and hsp90 levels and serum cytokine profiles are determined by the disease, patient age, and anti-leukemic treatment

Phase 2 clinical trial of 5-azacitidine, valproic acid, and all-trans retinoic acid in patients with high-risk acute myeloid leukemia or myelodysplastic syndrome

(2015)   Oncotarget

The Pretransplantation Serum Cytokine Profile in Allogeneic Stem Cell Recipients Differs from Healthy Individuals, and Various Profiles are Associated with Different Risks of Posttransplantation Complications

(2011) Håkon Reikvam et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Human Tumor Cells Killed by Anthracyclines Induce a Tumor-Specific Immune Response

(2011) J. Fucikova et al.   CANCER RESEARCH

Hematologic improvement and response in elderly AML/RAEB patients treated with valproic acid and low-dose Ara-C

(2011) M.T. Corsetti et al.   LEUKEMIA RESEARCH

The chemokine system in allogeneic stem-cell transplantation: a possible therapeutic target?

(2011) Guro Kristin Melve et al.   Expert Review of Hematology

Recurrent expression signatures of cytokines and chemokines are present and are independently prognostic in acute myelogenous leukemia and myelodysplasia

(2010) S. M. Kornblau et al.   BLOOD

Interleukin 1 receptor antagonist (IL1RA) in acute leukaemia: IL1RA is both secreted spontaneously by myelogenous leukaemia blasts and is a part of the acute phase reaction in patients with chemotherapy- induced leucopenia

(2010) Øystein Bruserud et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Immunological and Inflammatory Functions of the Interleukin-1 Family

(2009) Charles A. Dinarello   Annual Review of Immunology

Immunogenic cell death modalities and their impact on cancer treatment

(2009) Oliver Kepp et al.   APOPTOSIS

Heat Shock Protein 90 – a Potential Target in the Treatment of Human Acute Myelogenous Leukemia

(2009) H. Reikvam et al.   CURRENT CANCER DRUG TARGETS

Targeted therapy in acute myeloid leukaemia: current status and future directions

(2009) Camilla Stapnes et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Platelet functions beyond hemostasis

(2009) S. S. SMYTH et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Clinical correlation of circulating heat shock protein 70 in acute leukemia

(2009) Chen-Hsiung Yeh et al.   LEUKEMIA RESEARCH

The prognostic significance of cytokine levels in newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromes

(2008) Apostolia Maria Tsimberidou et al.   CANCER

Induction of leukemia-specific antibodies by immunotherapy with leukemia-cell-derived heat shock protein 70

(2008) Junko Jimbo et al.   CANCER SCIENCE

Significance of heat-shock protein (HSP) 90 expression in acute myeloid leukemia cells

(2008) Pascale Flandrin et al.   CELL STRESS & CHAPERONES

In vivobiological effects of ATRA in the treatment of AML

(2008) Anita Ryningen et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

A subset of patients with high-risk acute myelogenous leukemia shows improved peripheral blood cell counts when treated with the combination of valproic acid, theophylline and all-trans retinoic acid

(2008) Anita Ryningen et al.   LEUKEMIA RESEARCH

Heat-shock protein 90 associates with N-terminal extended peptides and is required for direct and indirect antigen presentation

(2008) M. K. Callahan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA